Home / Inspections / 1017417

FDA Inspection 1017417 — Bayer Healthcare Pharmaceuticals Inc.

Bayer Healthcare Pharmaceuticals Inc. — FEI 2243252

The FDA completed an inspection of Bayer Healthcare Pharmaceuticals Inc. on June 27, 2017 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Whippany, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1286004 (NAI Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277153 (NAI Fri Aug 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1251837 (NAI Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1196111 (NAI Wed Feb 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1153395 (NAI Wed Sep 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources